Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Girindra Raval"'
Autor:
Nicolas Sayegh, Juliet Yirerong, Neeraj Agarwal, Daniel Addison, Michael Fradley, Jorge Cortes, Neal L. Weintraub, Nazish Sayed, Girindra Raval, Avirup Guha
Publikováno v:
Current Cardiology Reports. 25:269-280
Autor:
David I. Marks, Shaji Kumar, Mei-Jie Zhang, Parameswaran Hari, Cesar O. Freytes, Wael Saber, Peter H. Wiernik, Navneet S. Majhail, Xiaobo Zhong, Edmund K. Waller, Baldeep Wirk, Jennifer M. Bird, Sagar Lonial, Nancy A. Brandenburg, Gregory A. Hale, Ruta Brazauskas, Jan S. Moreb, Rammurti T. Kamble, Girindra Raval, Richard F. Olsson, Amrita Krishnan, Dan T. Vogl, Roger H. Herzig, Jason Tay, Bipin N. Savani, Anuj Mahindra, Robert Peter Gale, Angela Dispenzieri, Gary J. Schiller, Hillard M. Lazarus, Paulette Mehta, Leona Holmberg
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, vol 21, iss 4
We describe baseline incidence and risk factors for new cancers in 4161 persons receiving autotransplants for multiple myeloma in the United States from 1990 to 2010. Observed incidence of invasive new cancers was compared with expected incidence rel
Publikováno v:
Clinical Chemistry. 57:1485-1488
A 51-year-old white male with history of osteoarthritis, hypertension, and insomnia presented to the hospital with a 1-month history of fatigue, as well as a 1-week history of back pain, nausea, and dark urine. The patient worked as a construction co
Autor:
Girindra Raval, Paulette Mehta
Publikováno v:
Drug, healthcare and patient safety
Biologic therapy has increasingly been used in the treatment of chronic diseases. Tumor necrosis factor (TNF) is a cytokine implicated in the pathogenesis of rheumatoid arthritis and inflammatory bowel disease. Anti-TNF therapy is being used in the t
Publikováno v:
American Journal of Hematology. 82:1022-1024
We report here a 57-year-old man treated with etanercept for 6 months for psoriasis who developed myelodysplasia with acute myeloid leukemia. Leukemia cells had distinct karyotype associated with poor prognosis. The patient did not respond to cytosin
Autor:
Ruta Brazauskas, Xiaobo Zhong, Parameswaran Hari, Angela Dispenzieri, Girindra Raval, Amrita Krishnan, Nancy A. Brandenburg, Sagar Lonial, Anuj Mahindra, Robert Peter Gale
Publikováno v:
Blood. 120:591-591
Abstract 591 Background: Survival of patients with MM has improved over the past two decades, in part due to the use of AHCT. Increasingly, second primary malignancies (SPMs) are observed in MM survivors. Determining the baseline incidence and risk f
Autor:
Girindra Raval
Publikováno v:
JAMA. 301:438
Publikováno v:
Blood. 112:4526-4526
Background Intractable hemorrhage is a dreaded complication after cardiovascular surgery often requiring re-exploration and the administration of large quantities of blood products. In view of problems with aprotinin, a new safer effective agent is n